Ruben Pio

About Ruben Pio

Ruben Pio, With an exceptional h-index of 49 and a recent h-index of 34 (since 2020), a distinguished researcher at Universidad de Navarra, specializes in the field of Lung cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Elevated expression of complement factor I in lung cancer cells associates with shorter survival-potentially via non-canonical mechanism.

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation

Fasting and fasting-mimicking conditions in the cancer immunotherapy era

Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung …

Data from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death

Upregulation of complement proteins in lung cancer cells mediates tumor progression

125 Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism

Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer

Ruben Pio Information

University

Position

Cima-

Citations(all)

8391

Citations(since 2020)

3891

Cited By

6019

hIndex(all)

49

hIndex(since 2020)

34

i10Index(all)

113

i10Index(since 2020)

91

Email

University Profile Page

Google Scholar

Ruben Pio Skills & Research Interests

Lung cancer

Top articles of Ruben Pio

Title

Journal

Author(s)

Publication Date

Elevated expression of complement factor I in lung cancer cells associates with shorter survival-potentially via non-canonical mechanism.

Translational Research

Anna Felberg

Michał Bieńkowski

Tomasz Stokowy

Kamil Myszczyński

Zuzanna Polakiewicz

...

2024/2/22

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation

Molecular Cancer

Ander Puyalto

María Rodríguez-Remírez

Inés López

Irati Macaya

Elizabeth Guruceaga

...

2024

Fasting and fasting-mimicking conditions in the cancer immunotherapy era

Ruben Pio

Yaiza Senent

Beatriz Tavira

Daniel Ajona

2024/4/8

Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung …

Jose Luis Perez-Gracia

Elisabet Guruceaga

Maria Pilar Andueza

Marimar Ocon

Nicolas de VIllalonga Zornoza

...

2023/6/1

Data from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death

Vicente Fresquet

Maria J Garcia-Barchino

Marta Larrayoz

Jon Celay

Carmen Vicente

...

2023/4/3

Upregulation of complement proteins in lung cancer cells mediates tumor progression

Frontiers in Oncology

Emily K Kleczko

Joanna M Poczobutt

Andre C Navarro

Jennifer Laskowski

Amber M Johnson

...

2023/1/5

125 Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism

Immunobiology

Anna Felberg

Michał Bieńkowski

Tomasz Stokowy

Kamil Myszczyński

Frida Mohlin

...

2023/9/1

Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer

EMBO reports

Ana Bocanegra

Gonzalo Fernández‐Hinojal

Daniel Ajona

Ester Blanco

Miren Zuazo

...

2023/8/3

Combined treatment with the epigenetic drug CM272 and an anti-BCL-XL proapoptotic drug sensitizes solid tumors to immune checkpoint blockade

Cancer Research

Yaiza Senent

Vicente Fresquet

Victoria Jimenez

Karmele Valencia

Ana Remirez

...

2023/4/4

Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma

Disease models & mechanisms

Karmele Valencia

Cristina Sainz

Cristina Bertolo

Gabriel de Biurrun

Jackeline Agorreta

...

2022/1/1

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d

Frontiers in Immunology

Daria Kowalska

Alicja Kuźniewska

Yaiza Senent

Beatriz Tavira

Susana Inogés

...

2022/8/24

Potent clinical predictive and systemic adjuvant therapeutic value of plasma fractalkine in PD-L1/PD-1 blockade immunotherapy for lung cancer

MedRxiv

Ana Bocanegra

Gonzalo Fernández

Daniel Ajona

Hugo Arasanz

Ester Blanco

...

2022/6/17

Tumor ENPP1 (CD203a)/Haptoglobin axis exploits myeloid-derived suppressor cells to promote post-radiotherapy local recurrence in breast cancer

Cancer discovery

Borja Ruiz-Fernández de Córdoba

Haritz Moreno

Karmele Valencia

Naiara Perurena

Pablo Ruedas

...

2022/5/2

The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells

Yaiza Senent

Beatriz Tavira

Ruben Pio

Daniel Ajona

2022/11/28

1298 A weakly supervised deep learning framework to predict KRAS-STK11 and KRAS-TP53 co-mutations in lung adenocarcinomas using H&E tissue sections

Daniel Jiménez-Sánchez

Carlos De Andrea

Álvaro López-Janeiro

Maria D Lozano

Carlos Ortiz-de-Solórzano

...

2022/11/1

170P Clonal hematopoiesis in asymptomatic individuals enrolled in a lung cancer screening program

Annals of Oncology

L Montuenga

P Aguirre-Ruiz

B Ariceta

M Mesa-Guzman

LM Seijo

...

2022/4/1

Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood

Bioengineering & Translational Medicine

Alejandro Rodríguez‐Pena

Estibaliz Armendariz

Alvaro Oyarbide

Xabier Morales

Sergio Ortiz‐Espinosa

...

2022/9

Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis

Cancer letters

Sergio Ortiz-Espinosa

Xabier Morales

Yaiza Senent

Diego Alignani

Beatriz Tavira

...

2022/3/31

967P The time of anti-PD-1 infusion improves survival outcomes by fasting conditions simulation in non-small cell lung cancer

Annals of Oncology

A Vilalta

H Arasanz

M Rodriguez-Remirez

I Lopez

A Puyalto

...

2021/9/1

Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma

Translational Lung Cancer Research

Ana Patiño-García

Elizabeth Guruceaga

Victor Segura

Rodrigo Sánchez Bayona

Maria Pilar Andueza

...

2021/3

See List of Professors in Ruben Pio University(Universidad de Navarra)